Healthcare

Cardio Diagnostics Leverages AI and Multi-Omic Biomarkers to Combat Cardiovascular Disease

Cardio Diagnostics Leverages AI and Multi-Omic Biomarkers to Combat Cardiovascular Disease

Cardio Diagnostics Holdings is advancing AI-driven blood tests for earlier, more personalized detection and management of cardiovascular disease, addressing the leading cause of death in the U.S.

April 27, 2026
8 Tips to Protect Your Vision as You Age, According to the National Eye Institute

8 Tips to Protect Your Vision as You Age, According to the National Eye Institute

The National Eye Institute offers eight actionable tips for maintaining eye health, emphasizing the importance of regular exams, healthy lifestyle choices, and managing chronic conditions to prevent vision loss.

April 27, 2026
Cardio Diagnostics Leverages AI and Genomics to Revolutionize Cardiovascular Disease Detection

Cardio Diagnostics Leverages AI and Genomics to Revolutionize Cardiovascular Disease Detection

Cardio Diagnostics Holdings (NASDAQ: CDIO) is advancing AI-powered solutions using simple blood tests to detect and manage cardiovascular disease, addressing the leading cause of death in the US.

April 27, 2026
Catalyst Crew Technologies CEO to Attend HLTH Europe 2026, Seeking Strategic Growth in Digital Health

Catalyst Crew Technologies CEO to Attend HLTH Europe 2026, Seeking Strategic Growth in Digital Health

Catalyst Crew Technologies Corp. announced its CEO will attend HLTH Europe 2026 to explore partnerships and market trends, supporting its expansion in AI-driven telehealth for emerging markets.

April 27, 2026
GeoVax Positions Gedeptin as Immune-Sensitizing Platform Amid Industry Shift to In Vivo Cancer Therapies

GeoVax Positions Gedeptin as Immune-Sensitizing Platform Amid Industry Shift to In Vivo Cancer Therapies

GeoVax highlights its gene-directed enzyme prodrug therapy Gedeptin as a potential immune-sensitizing platform that could enhance checkpoint inhibitor efficacy in solid tumors, aligning with rising industry investment in simplified in vivo cancer treatments.

April 27, 2026
Nearly 1,300 Learn CPR at NFL Draft, Setting Guinness World Record

Nearly 1,300 Learn CPR at NFL Draft, Setting Guinness World Record

The American Heart Association, NFL, Damar Hamlin's Chasing M's Foundation, and Doctor Mike trained 1,293 people in Hands-Only CPR in one hour at the NFL Draft, setting a Guinness World Record and advancing the Nation of Lifesavers movement to double cardiac arrest survival by 2030.

April 27, 2026
Doyle Orthodontics Opens Three Locations Across Southwestern Pennsylvania

Doyle Orthodontics Opens Three Locations Across Southwestern Pennsylvania

Dr. Cullen Doyle launches three orthodontic practices in Pittsburgh, Washington, and Pleasant Hills, PA, aiming to reduce travel barriers while maintaining consistent, personalized care.

April 27, 2026
Advanced Heart, Kidney and Metabolic Syndrome Linked to 30% Higher Cancer Risk, Study Finds

Advanced Heart, Kidney and Metabolic Syndrome Linked to 30% Higher Cancer Risk, Study Finds

New research published in Circulation: Population Health and Outcomes reveals that later stages of cardiovascular-kidney-metabolic (CKM) syndrome are associated with a 25-30% increased risk of cancer, highlighting the need for integrated screening.

April 27, 2026
Cardio Diagnostics' AI Platform Aims to Transform Cardiovascular Risk Assessment

Cardio Diagnostics' AI Platform Aims to Transform Cardiovascular Risk Assessment

Cardio Diagnostics Holdings uses artificial intelligence and multi-omic data from a simple blood draw to provide personalized cardiovascular risk assessments, potentially shifting heart health diagnostics from population-based models to precise, individualized insights.

April 24, 2026
LIXTE Biotechnology Advances Precision Cancer Treatment with Novel PP2A Inhibitor

LIXTE Biotechnology Advances Precision Cancer Treatment with Novel PP2A Inhibitor

LIXTE Biotechnology is pioneering a new approach in oncology with its lead compound LB-100, which enhances chemotherapy and radiation efficacy while reducing side effects, potentially improving patient outcomes.

April 24, 2026
Survey Reveals American Adults Demand Elimination of Health Inequities

Survey Reveals American Adults Demand Elimination of Health Inequities

A survey by Johns Hopkins School of Nursing's Institute for Policy Solutions finds that American adults strongly support eliminating health inequities, urging policymakers to act.

April 24, 2026
HeartBeam Partners with Mount Sinai to Develop AI-Driven ECG Algorithms

HeartBeam Partners with Mount Sinai to Develop AI-Driven ECG Algorithms

HeartBeam's collaboration with Mount Sinai aims to advance AI-enabled ECG analysis, reinforcing its role in the shift toward data-driven remote cardiac monitoring.

April 24, 2026
Earth Science Tech Positions Itself for Telehealth's Next Phase with Integrated Platform

Earth Science Tech Positions Itself for Telehealth's Next Phase with Integrated Platform

Earth Science Tech Inc. is aligning with the evolution of telehealth from simple video visits to a comprehensive care model through its integrated platform that combines telemedicine, compounding pharmaceuticals, and patient services.

April 24, 2026
Hansen Orthodontics Expands Invisalign Availability in Wichita Under Founder's Direct Oversight

Hansen Orthodontics Expands Invisalign Availability in Wichita Under Founder's Direct Oversight

Hansen Orthodontics increases Invisalign appointment capacity for spring 2026, emphasizing founder-led care and Silver Plus provider status as alternatives to corporate dental chains.

April 24, 2026
Telomir Pharmaceuticals Closes TELI Acquisition, Secures Global Rights to Lead Drug Candidate

Telomir Pharmaceuticals Closes TELI Acquisition, Secures Global Rights to Lead Drug Candidate

Telomir Pharmaceuticals completed its acquisition of TELI Pharmaceuticals, obtaining sole global rights to Telomir-1, a drug aimed at treating advanced breast cancer and targeting aging-related diseases, with a $1 million upfront payment and up to $4 million in milestones.

April 24, 2026
Lantern Pharma to Showcase AI Co-Scientist Platform withZeta.ai in Live Public Demo

Lantern Pharma to Showcase AI Co-Scientist Platform withZeta.ai in Live Public Demo

Lantern Pharma will host its first live demonstration of the withZeta.ai AI co-scientist platform on April 30, 2026, showcasing its ability to accelerate oncology drug discovery and marking a potential new revenue stream through a subscription model.

April 24, 2026
SureNano Science Advances GLP-1 Drug Candidate Toward Clinical Trials, Expands Investor Outreach

SureNano Science Advances GLP-1 Drug Candidate Toward Clinical Trials, Expands Investor Outreach

SureNano Science Ltd. is moving its lead obesity and diabetes drug GEP-44 into FDA IND-enabling studies with LabCorp while broadening investor communications through a partnership with Investor Brand Network.

April 24, 2026
Scinai Immunotherapeutics Raises $2.61M to Expand CDMO Platform and Advance Pipeline

Scinai Immunotherapeutics Raises $2.61M to Expand CDMO Platform and Advance Pipeline

Scinai Immunotherapeutics announced a $2.61 million private placement and warrant inducement, with proceeds supporting its CDMO expansion and immunotherapy pipeline.

April 24, 2026
Strawberry Fields REIT to Report Q1 2026 Earnings, Highlighting Skilled Nursing Portfolio Performance

Strawberry Fields REIT to Report Q1 2026 Earnings, Highlighting Skilled Nursing Portfolio Performance

Strawberry Fields REIT announced its first quarter 2026 earnings release and conference call, providing investors with insights into the performance of its 143 healthcare facilities across 10 states.

April 24, 2026
Oncotelic Therapeutics Featured in NetworkNewsAudio Editorial Highlighting How Late-Stage Drug Pipelines Drive Valuation in Biotech

Oncotelic Therapeutics Featured in NetworkNewsAudio Editorial Highlighting How Late-Stage Drug Pipelines Drive Valuation in Biotech

Oncotelic Therapeutics, Inc. (OTCQB: OTLC) is featured in a NetworkNewsAudio editorial that explores how advancing drug pipelines, particularly those near commercialization, create significant value in biopharma, directly relevant to Oncotelic's oncology-focused pipeline.

April 24, 2026
Catalyst Crew Technologies Advances Telehealth Platform Deployment and Regulatory Approvals in Venezuela

Catalyst Crew Technologies Advances Telehealth Platform Deployment and Regulatory Approvals in Venezuela

Catalyst Crew Technologies Corp. is progressing with early-stage testing and regulatory alignment for its AI-driven telehealth platform in Venezuela, aiming to expand digital healthcare access in Latin America.

April 24, 2026
Oncotelic Therapeutics Highlights Partnership Strategy to Advance Pipeline and Boost Shareholder Value

Oncotelic Therapeutics Highlights Partnership Strategy to Advance Pipeline and Boost Shareholder Value

Oncotelic Therapeutics updates its partnership-driven strategy, citing a $249 million valuation boost from its GMP Biotechnology joint venture and plans for further collaborations to advance its oncology pipeline efficiently.

April 24, 2026
Lakeville Clinic Reports Early Neuropathy Improvement in Patient After Two Weeks

Lakeville Clinic Reports Early Neuropathy Improvement in Patient After Two Weeks

ALIGN Integrated Health in Lakeville, Minnesota reports that a Burnsville patient showed measurable improvement in neuropathy symptoms within two weeks of starting integrative treatment, highlighting the importance of early intervention.

April 24, 2026
American Heart Association and NFL Award $350,000 in Grants to Schools for Student Health and CPR Readiness

American Heart Association and NFL Award $350,000 in Grants to Schools for Student Health and CPR Readiness

The American Heart Association and NFL have awarded grants to 188 schools across 45 states to support physical activity, emergency readiness, and CPR training, addressing childhood obesity and cardiac emergency preparedness.

April 24, 2026
Dental Implants Can Be Affordable: Strategic Approaches to Save Without Sacrificing Quality

Dental Implants Can Be Affordable: Strategic Approaches to Save Without Sacrificing Quality

The article outlines the costs of dental implants in 2026 and provides ten proven strategies to make them more affordable, emphasizing informed decision-making and value over low price.

April 24, 2026
SS Innovations Unveils Drone, Humanoid, and Mobile OR Robotic Systems for Battlefield and Remote Surgery

SS Innovations Unveils Drone, Humanoid, and Mobile OR Robotic Systems for Battlefield and Remote Surgery

SS Innovations showcased futuristic surgical robots at SMRSC 2026, including a drone-deployed system for combat zones and a humanoid platform, aiming to expand access to robotic surgery globally.

April 24, 2026
Catalyst Crew Technologies Appoints Vilma Casanova as COO to Drive Telehealth Expansion in Venezuela

Catalyst Crew Technologies Appoints Vilma Casanova as COO to Drive Telehealth Expansion in Venezuela

Catalyst Crew Technologies Corp. has appointed Vilma Casanova as Chief Operating Officer to oversee the operational execution and scaling of its telehealth platform in Venezuela.

April 24, 2026
Tonix Pharmaceuticals Presents Preclinical Immuno-Oncology Data at AACR 2026, Highlighting Potential in Gastric Cancer and Immunotherapy

Tonix Pharmaceuticals Presents Preclinical Immuno-Oncology Data at AACR 2026, Highlighting Potential in Gastric Cancer and Immunotherapy

Tonix Pharmaceuticals announced new preclinical data for TNX-1700 and TNX-4700 at AACR 2026, showing potential in gastric cancer and as a BTLA-targeting immunotherapy, which could expand its oncology pipeline.

April 24, 2026
Helus Pharma Appoints Robert Langer and Stephen Brannan to Scientific Advisory Board, Bolstering Neuroscience Pipeline

Helus Pharma Appoints Robert Langer and Stephen Brannan to Scientific Advisory Board, Bolstering Neuroscience Pipeline

Helus Pharma adds renowned experts Dr. Robert Langer and Dr. Stephen Brannan to its Scientific Advisory Board, strengthening its drug development capabilities for mental health treatments including major depressive disorder and generalized anxiety disorder.

April 24, 2026
Novel Urine Test May Predict Bladder Cancer Treatment Response

Novel Urine Test May Predict Bladder Cancer Treatment Response

Researchers have developed a urine test that detects tumor DNA to predict residual bladder cancer after surgery and assess immunotherapy effectiveness.

April 24, 2026
PreviousPage 5 of 78Next